Dual Antibiotic-Infused Liposomes to Control Methicillin-Resistant Staphylococcus aureus

Area of Science:

• Nanotechnology
• Microbiology
• Pharmacology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant public health threat, necessitating novel therapeutic strategies.
• Existing treatments face challenges due to antibiotic resistance, driving the need for innovative solutions.
• The Centers for Disease Control and Prevention (CDC) categorize MRSA as a serious threat.

Purpose of the Study:

• To develop and characterize novel ethosome-like liposomes for enhanced antibiotic delivery.
• To evaluate the antimicrobial efficacy of dual antibiotic-loaded liposomes against MRSA.
• To assess the potential of these liposomes in eradicating MRSA biofilms.

Main Methods:

• Ethosome-like liposomes were synthesized and characterized using DLS, FTIR, and SEM.
• Encapsulation efficiency and release kinetics were determined to confirm antibiotic loading.
• Antimicrobial activity was assessed via MIC, crystal violet assay, and live/dead biofilm assays.

Main Results:

• Liposomes successfully encapsulated ampicillin and amikacin, demonstrating sustained release properties.
• Tocopherol incorporation provided potential anti-inflammatory benefits.
• The developed liposomes exhibited significant antimicrobial activity against MRSA and effectively eradicated mature biofilms.

Conclusions:

• Dual antibiotic-encapsulated liposomes offer a promising dual-targeted approach for combating MRSA.
• These liposomes can serve as an advanced drug delivery vehicle for conventional antibiotics.
• This strategy holds potential for developing novel anti-infective agents against resistant bacteria.